AI-guided design enables E. coli ribosomal proteins without isoleucine
Researchers used computational protein design and generative AI to recode ribosomal proteins in E. coli so they function without isoleucine, then assembled an engineered strain that remained viable and genomically stable over more than 450 laboratory generations. The result shows a reduced amino-acid alphabet can support core translation machinery in this bacterium; the organism still uses isoleucine elsewhere.
Technology: Protein design models including ESM2, MSATr, ProteinMPNN and AfDesign
Family ESM / ESMFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Researchers used computational protein design and generative AI to recode ribosomal proteins in E. coli so they function without isoleucine, then assembled an engineered strain that remained viable and genomically stable over more than 450 laboratory generations.
- Still unknown: This is not a whole 19-amino-acid organism: isoleucine was eliminated from the engineered ribosomal proteins, while the rest of the cell still uses it. Growth was slower than wild type according to the paper.
- AI role: The researchers used AI-guided computational design to propose amino-acid substitutions that allowed selected ribosomal proteins to function after removing isoleucine; the strain was assembled and experimentally tested by the team.
Evidence sources: https://magazine.columbia.edu/article/could-life-be-made-simpler
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.